You are here: Home » Reuters » News
Business Standard

Theranos and its founder settle U.S. fraud charges - SEC

Reuters  |  WASHINGTON 

By Pete SchroederWASHINGTON (Reuters) - Embattled blood-testing company Theranos Inc and its Chief Executive Elizabeth Holmes agreed to settle "massive fraud" charges in a deal that strips her of majority control among other penalties, U.S. regulators said on Wednesday.Theranos was once hailed as a Silicon Valley star, with a $9 billion valuation based on its promise to disrupt the staid laboratory testing business with new technology the company claimed could analyse a single drop of blood. Founded in 2003, its fortunes began to wane in 2015 after Wall Street Journal reports suggested its ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Wed, March 14 2018. 23:50 IST